SearchDictionaryMobileLogin

Antonia Trichopoulou Selected Research

Neoplasms (Cancer)

09/2008Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study.
08/2008Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
07/2008Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
06/2008Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
05/2008Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
02/2008Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.
11/2007The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition.
09/2007Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
09/2007Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
09/2007Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.
07/2007Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
06/2007Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
06/2007Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
03/2007Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
03/2007Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.
01/2007Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
12/2006Ethanol intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
12/2006Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition.
11/2006Tobacco smoke and bladder cancer--in the European Prospective Investigation into Cancer and Nutrition.
11/2006Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
08/2006Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
07/2006TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.
07/2006Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study.
05/2006No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.
02/2006Plasma C-reactive protein and risk of cancer: a prospective study from Greece.
11/2005Mediterranean diet in relation to body mass index and waist-to-hip ratio: the Greek European Prospective Investigation into Cancer and Nutrition Study.
10/2005Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
08/2005Variations in lycopene blood levels and tomato consumption across European countries based on the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
06/2005C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
05/2005Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
10/2004Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study.
09/2004Amount of DNA in plasma and cancer risk: a prospective study.
09/2004Plasma levels of six carotenoids in nine European countries: report from the European Prospective Investigation into Cancer and Nutrition (EPIC).
10/2003Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract.
08/2003Group level validation of protein intakes estimated by 24-hour diet recall and dietary questionnaires against 24-hour urinary nitrogen in the European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study.

Articles by Research Topic

Disease

35Neoplasms (Cancer)
09/2008 - 08/2003
7Breast Neoplasms (Breast Cancer)
07/2008 - 05/2005
6Prostatic Neoplasms (Prostate Cancer)
05/2008 - 06/2007
4Endometrial Neoplasms (Endometrial Cancer)
06/2008 - 01/2007
4Lung Neoplasms (Lung Cancer)
11/2007 - 09/2005
4Stomach Neoplasms (Stomach Cancer)
11/2007 - 07/2006
2Ovarian Neoplasms (Ovarian Cancer)
03/2007 - 01/2007
2Coronary Disease (Coronary Heart Disease)
04/2005 - 08/2004
1Syndrome
09/2007
1Rectal Neoplasms (Rectal Cancer)
07/2007
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2006
1Adenocarcinoma
05/2006

Drug/Important Bio-Agent (IBA)

5Insulin-Like Growth Factor I (IGF-1)IBA
07/2008 - 06/2005
4SmokeIBA
11/2007 - 11/2006
4C-PeptideIBA
07/2007 - 06/2005
2DNA AdductsIBA
09/2008 - 09/2005
2Gonadal Steroid Hormones (Sex Hormones)IBA
06/2008 - 06/2005
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
02/2008 - 11/2007
2AndrogensIBA
09/2007 - 01/2007
2Carotenoids (Carotene)IBA
09/2007 - 09/2004
2Insulin-Like Growth Factor Binding Protein 2IBA
07/2007 - 06/2007
2Insulin-Like Growth Factor Binding Protein 1IBA
07/2007 - 06/2007
2Insulin (Novolin)FDA Link
06/2007 - 10/2005
2DNA (Deoxyribonucleic Acid)IBA
07/2006 - 09/2004
2SteroidsIBA
06/2006 - 05/2005
1Hemoglobins (Hemoglobin)IBA
08/2008
1Insulin-Like Growth Factor Binding Protein 3IBA
07/2008
1GhrelinIBA
07/2008
1Dietary Fats (Ghee)IBA
05/2008
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
11/2007
1Estrogen Receptor betaIBA
10/2007
1Glucose (Dextrose)FDA LinkGeneric
09/2007
1Lipoproteins (Lipoprotein)IBA
09/2007
1TocopherolsFDA Link
09/2007
1Vitamin A (Retinol)FDA Link
09/2007
1Acetyl-CoA CarboxylaseIBA
03/2007
1Carrier Proteins (Binding Protein)IBA
03/2007
1AdiponectinIBA
01/2007
1Ethanol (Ethyl Alcohol)IBA
12/2006
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
11/2006
1Nitroso CompoundsIBA
07/2006
1HormonesIBA
06/2006
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
05/2006
1C-Reactive ProteinIBA
02/2006
1Growth Hormone (Somatotropin)IBA
10/2005
1lycopeneIBA
08/2005
1olive oilIBA
10/2004
1NitrogenIBA
08/2003

Therapy/Procedure

5Mediterranean Diet
11/2005 - 10/2003